"The following presentation does not indicate that NextGen IP is successful in targeting cancer cells; it is merely and illustration of the theory behind NextGen's stem cell targets. NextGen patented IP aims to identify the original stem cells of the cancer and fight them; if successful this could reverse the proliferation of the cancerous cells while stimulating the growth of healthy cells and potentially remove the cancer. NextGen's IP is in an early stage of development and its ability to affect the growth of cancerous cells cannot be proven".

Please click here to watch the presentation